MegaPro Biomedical Co (ROCO:6827) EBITDA Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6827 MegaPro Biomedical Co Ltd ROCO:6827
33 GF Score
Price NT$10.70
View Full Analysis

What is MegaPro Biomedical Co EBITDA Margin %?

MegaPro Biomedical Co ROCO:6827 -2.28% 33 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates ROCO:6827 with a GF Score™ of 33/100. Among 939 Biotechnology companies, MegaPro Biomedical Co ranks worse than 106496.17% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. MegaPro Biomedical Co's EBITDA for the six months ended in Dec. 2025 was NT$-45.52 Mil. MegaPro Biomedical Co's Revenue for the six months ended in Dec. 2025 was NT$0.00 Mil. Therefore, MegaPro Biomedical Co's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.

MegaPro Biomedical Co  (ROCO:6827) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

MegaPro Biomedical Co EBITDA Margin % Related Terms

MegaPro Biomedical Co EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for MegaPro Biomedical Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MegaPro Biomedical Co EBITDA Margin % Chart

MegaPro Biomedical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial 0.00 0.00 -614,655.56 -1,045,592.86 0.00

MegaPro Biomedical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -314,400.00 -487,571.43 0.00 0.00 0.00

ROCO:6827 vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, MegaPro Biomedical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MegaPro Biomedical Co EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MegaPro Biomedical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where MegaPro Biomedical Co's EBITDA Margin % falls into.


ROCO:6827
33GF Score
MegaPro Biomedical Co Ltd ROCO:6827
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MegaPro Biomedical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

MegaPro Biomedical Co's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-103.91/0
= %

MegaPro Biomedical Co's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-45.516/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
MegaPro Biomedical Co (ROCO:6827) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MegaPro Biomedical Co and its competitors. According to the industry distribution chart, MegaPro Biomedical Co ranks #999999 out of 939 companies in the Biotechnology industry.
Is MegaPro Biomedical Co's EBITDA Margin % too high?
MegaPro Biomedical Co's current EBITDA Margin % is 0.00%. Based on the distribution chart, MegaPro Biomedical Co ranks #999999 out of 939 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, MegaPro Biomedical Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does MegaPro Biomedical Co's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, MegaPro Biomedical Co ranks #999999 out of 939 companies for EBITDA Margin %. This places MegaPro Biomedical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MegaPro Biomedical Co and its competitors. MegaPro Biomedical Co's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MegaPro Biomedical Co stock overvalued right now?
MegaPro Biomedical Co (ROCO:6827) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. MegaPro Biomedical Co's overall GF Score™ is 33/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For MegaPro Biomedical Co (ROCO:6827), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MegaPro Biomedical Co Business Description

Address No. 66, Shengyi 5th Road, 10F-1, Hsinchu Science Park, Hsinchu, TWN, 31040
MegaPro Biomedical Co Ltd is a nanomedicine development company. The Company's only reportable operating segment is the Drug Application Development segment, which is engaged in the development of nano-iron oxide IOP drugs.
33GF Score

Get the complete analysis for ROCO:6827

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$10.70
Price